{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:56Z","timestamp":1791216056508,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T00:00:00Z","timestamp":1427328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00259-015-3036-3","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T16:21:02Z","timestamp":1427300462000},"page":"1025-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Carmela","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Altiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina Anna","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Tommaso","family":"Diomiaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"3036_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM. \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw Hill; 2001. p. 3733\u201374.","edition":"8"},{"key":"3036_CR2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM; European FOS investigators. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007;28:1228\u201335.","journal-title":"Eur Heart J"},{"key":"3036_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, et al. Fabry registry. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab. 2008;93:112\u201328.","journal-title":"Mol Genet Metab"},{"key":"3036_CR4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, Warnock DG, Banikazemi M, Bultas J, Linthorst GE, Packman S, et al. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant. 2009;24:2102\u201311.","journal-title":"Nephrol Dial Transplant"},{"key":"3036_CR5","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JC Moon","year":"2003","unstructured":"Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003;24:2151\u20135.","journal-title":"Eur Heart J"},{"key":"3036_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","volume":"8","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Sanchez-Ni\u00f1o MD, Politei J, Oliveira JP, Wanner C, Warnock DG, et al. Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis. 2013;8:116.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 2","key":"3036_CR7","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.2967\/jnumed.113.129262","volume":"55","author":"O Ratib","year":"2014","unstructured":"Ratib O, Nkoulou R. Potential applications of PET\/MR imaging in cardiology. J Nucl Med. 2014;55 Suppl 2:40S\u20136S.","journal-title":"J Nucl Med"},{"key":"3036_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2967\/jnumed.112.105353","volume":"54","author":"C Rischpler","year":"2013","unstructured":"Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET\/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med. 2013;54:402\u201315.","journal-title":"J Nucl Med"},{"key":"3036_CR9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57:891\u2013903.","journal-title":"J Am Coll Cardiol"},{"key":"3036_CR10","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"3036_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cjca.2012.11.033","volume":"29","author":"J Stirrat","year":"2013","unstructured":"Stirrat J, White JA. The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy. Can J Cardiol. 2013;29:329\u201336.","journal-title":"Can J Cardiol"},{"key":"3036_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1532-429X-14-22","volume":"14","author":"D O h-Ici","year":"2012","unstructured":"O h-Ici D, Ridgway JP, Kuehne T, Berger F, Plein S, Sivananthan M, et al. Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson. 2012;14:22.","journal-title":"J Cardiovasc Magn Reson"},{"key":"3036_CR13","first-page":"742","volume":"38","author":"J Dahl vom","year":"1997","unstructured":"vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med. 1997;38:742\u20138.","journal-title":"J Nucl Med"},{"key":"3036_CR14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1148\/rg.315105222","volume":"31","author":"OG James","year":"2011","unstructured":"James OG, Christensen JD, Wong TZ, Borges-Neto S, Koweek LM. Utility of FDG PET\/CT in inflammatory cardiovascular disease. Radiographics. 2011;31:1271\u201386.","journal-title":"Radiographics"},{"key":"3036_CR15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2967\/jnumed.112.105155","volume":"54","author":"S Dorbala","year":"2013","unstructured":"Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI\/ASNC\/SCCT guideline for cardiac SPECT\/CT and PET\/CT 1.0. J Nucl Med. 2013;54:1485\u2013507.","journal-title":"J Nucl Med"},{"key":"3036_CR16","doi-asserted-by":"crossref","first-page":"W151","DOI":"10.2214\/AJR.07.2409","volume":"190","author":"G Williams","year":"2008","unstructured":"Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008;190:W151\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"3036_CR17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.108.055616","volume":"50","author":"J Wykrzykowska","year":"2009","unstructured":"Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET\/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med. 2009;50:563\u20138.","journal-title":"J Nucl Med"},{"key":"3036_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/PREACCEPT-4280658695831343","volume":"14","author":"MS Nacif","year":"2012","unstructured":"Nacif MS, Arai AE, Lima JA, Bluemke DA. Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines. J Cardiovasc Magn Reson. 2012;14:18.","journal-title":"J Cardiovasc Magn Reson"},{"key":"3036_CR19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-011-1832-y","volume":"38","author":"H Ohira","year":"2011","unstructured":"Ohira H, Tsujino I, Yoshinaga K. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38:1773\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3036_CR20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","volume":"3","author":"N Tahara","year":"2010","unstructured":"Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2010;3:1219\u201328.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3036_CR21","doi-asserted-by":"crossref","first-page":"e91757","DOI":"10.1371\/journal.pone.0091757","volume":"9","author":"A Feustel","year":"2014","unstructured":"Feustel A, Hahn A, Schneider C, Sieweke N, Franzen W, G\u00fcnd\u00fcz D, et al. Continuous cardiac troponin I release in Fabry disease. PLoS One. 2014;9:e91757.","journal-title":"PLoS One"},{"key":"3036_CR22","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","volume":"284","author":"RO Brady","year":"2000","unstructured":"Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA. 2000;284:2771\u20135.","journal-title":"JAMA"},{"key":"3036_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2012.08.003","volume":"107","author":"A Pisani","year":"2012","unstructured":"Pisani A, Visciano B, Roux GD, Sabbatini M, Porto C, Parenti G, et al. Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. Mol Genet Metab. 2012;107:267\u201375.","journal-title":"Mol Genet Metab"},{"key":"3036_CR24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, St\u00f6rk S, et al. Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119:524\u20139.","journal-title":"Circulation"},{"key":"3036_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, et al. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab. 2008;95:163\u20138.","journal-title":"Mol Genet Metab"},{"key":"3036_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","volume":"47","author":"T DeGraba","year":"2000","unstructured":"DeGraba T, Azhar S, Dignat-George F, Brown E, Bouti\u00e8re B, Altarescu G, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47:229\u201333.","journal-title":"Ann Neurol"},{"key":"3036_CR27","first-page":"226","volume":"2012","author":"GB Biancini","year":"1822","unstructured":"Biancini GB, Vanzin CS, Rodrigues DB, Deon M, Ribas GS, Barschak AG, et al. Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy. Biochim Biophys Acta. 1822;2012:226\u201332.","journal-title":"Biochim Biophys Acta"},{"key":"3036_CR28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","volume":"4","author":"M Niemann","year":"2011","unstructured":"Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, et al. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011;4:592\u2013601.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3036_CR29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2967\/jnumed.107.041574","volume":"48","author":"E Inglese","year":"2007","unstructured":"Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET\/CT. J Nucl Med. 2007;48:1662\u20139.","journal-title":"J Nucl Med"},{"key":"3036_CR30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","volume":"188","author":"M Imbriaco","year":"2007","unstructured":"Imbriaco M, Spinelli L, Cuocolo A, Maurea S, Sica G, Quarantelli M, et al. MRI characterization of myocardial tissue in patients with Fabry\u2019s disease. AJR Am J Roentgenol. 2007;188:850\u20133.","journal-title":"AJR Am J Roentgenol"},{"key":"3036_CR31","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1259\/bjr\/52065763","volume":"83","author":"M Imbriaco","year":"2010","unstructured":"Imbriaco M, Messalli G, Avitabile G, Cuocolo A, Maurea S, Soscia F, et al. Cardiac magnetic resonance imaging illustrating Anderson-Fabry disease progression. Br J Radiol. 2010;83:e249\u201351.","journal-title":"Br J Radiol"},{"key":"3036_CR32","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1161\/CIRCULATIONAHA.112.001217","volume":"127","author":"JA White","year":"2013","unstructured":"White JA, Rajchl M, Butler J, Thompson RT, Prato FS, Wisenberg G. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography\u2013magnetic resonance imaging for the diagnosis of cardiac disease. Circulation. 2013;127:e639\u201341.","journal-title":"Circulation"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3036-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3036-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T01:16:09Z","timestamp":1717809369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3036-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3036"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3036-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]}}}